You have no items in your shopping cart.
Human IL-36 Beta [orb2993917]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC.(QC verified)
Predicted: 17.2 KDa. Observed: 17 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Human IL-36 Beta [orb2994224]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.7 KDa. Observed: 18 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human IL-36 beta Protein, His Tag [orb1551457]
> 92% by SDS-PAGE.
Recombinant Human IL-36 beta Protein is produced by E. coli expression system. The target protein is expressed with sequence (Arg5-Glu157) of human IL-36 beta (Accession #NP_775270.1) fused with a 6��His Tag at the C-terminus.
100 μg, 50 μg - IL-36 beta Recombinant Protein [orb1230128]
>95% (SDS-PAGE). Endotoxin level is less than 0.01EU/ μg purified protein (LAL test; Lonza).
E. coli
10 μg - IL-36 beta Recombinant Protein [orb1228442]
Greater than 95% as determined by reducing SDS-PAGE.Endotoxin level less than 0.1 ng/ug (1 IEU/ug) as determined by LAL test.
17.6 kD
E. coli
0.05 mg ELISA
>98% as determined by SDS-PAGE. Ni-NTA chromatography.
Escherichia coli
5 μg, 20 μg, 100 μg, 500 μg, 1 mg